Currently predicting for Thu, 4 Jun 2026

ABBV Prediction Chart

ABBV Predictions History

Latest community submissions for ABBV.
Predictor Target Session Target Price Result Direction Accuracy Score
Jan 9, 2024 $160.47 -0.59% $162.31 X 98.87% 1
Jan 9, 2024 $160.83 -0.37% $162.31 X 99.09% 1
Jan 9, 2024 Bullish $162.31 V 1
Jan 4, 2024 $159.54 -0.58% $161.46 X 98.81% 1
Jan 4, 2024 $159.88 -0.36% $161.46 X 99.02% 1
Jan 4, 2024 Bullish $161.46 V 1
SonaCortado SonaCortado Merchant
Jul 31, 2023 $148.67 -1.45% $149.58 V 99.39% 4
Jul 17, 2023 $135.07 -0.69% $134.83 V 99.82% 6
Jul 17, 2023 $135.42 -0.43% $134.83 V 99.56% 5
Jul 17, 2023 Bullish $134.83 X 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ABBV with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ABBVIE INC
AbbVie
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia ...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE